Antithrombotic Therapy for Atrial Fibrillation

Professor Gregory Lip; Amitava Banerjee; Giuseppe Boriani; Chern En Chiang; Ramiz Fargo; Ben Freedman; Deirdre A. Lane; Christian T. Ruff; Mintu P. Turakhia; David J. Werring; Sheena Patel; Lisa K. Moores

doi:10.1016/j.chest.2018.07.040

Letter2022

Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease

Ying X. Gue, Diana A. Gorog, Professor Gregory Lip

Article2017

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Christopher P. Cannon, Deepak L. Bhatt, Jonas Oldgren, Professor Gregory Lip, Stephen G. Ellis, Takeshi Kimura, Michael Mæng, Béla Merkely, Uwe Zeymer, Savion Gropper, Matias Nordaby, Eva Kleine, Ruth Harper, Jenny Manassie, James L. Januzzi, Jurriën M. ten Berg, Philippe Gabríel Steg, Stefan H. Hohnloser

Article2019

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

Davide Capodanno, Kurt Huber, Roxana Mehran, Professor Gregory Lip, David P. Faxon, Christopher B. Granger, Pascal Vranckx, Renato D. Lópes, Gilles Montalescot, Christopher P. Cannon, Jurien Ten Berg, Bernard J. Gersh, Deepak L. Bhatt, Dominick J. Angiolillo

Article2022

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease

So-Ryoung Lee, Jin‐Hyung Jung, Eue-Keun Choi, Seung‐Woo Lee, Soonil Kwon, Ji-Suck Park, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2022

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program

Lea Beier, Shihai Lu, Lionel Riou França, Sabrina Marler, Professor Gregory Lip, Menno V. Huisman, Christine Teutsch, Jonathan L. Halperin, Kristina Zint, Hans‐Christoph Diener, Laurie Baker, Changsheng Ma, Miney Paquette, Dorothee B. Bartels, Sérgio Dubner, Philippe Lyrer, Jochen Senges, Kenneth J. Rothman

Antithrombotic Therapy for Atrial Fibrillation

Discussion(0)

Related publications

Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program